Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma

Genes Chromosomes and Cancer

Volumn 49, Issue 1, 2010, Pages 9-16

  Freier, Kolja ^a,b   Knoepfle, Karl ^a,b   Flechtenmacher, Christa ^b   Pungs, Susanne ^b   Devens, Frauke ^a   Toedt, Grischa ^a   Hofele, Christof ^b   Joos, Stefan ^a   Lichter, Peter ^a   Radlwimmer, Bernhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CYCLIN E1; MESSENGER RNA; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME NUMBER; CHROMOSOME POSITIONING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TRANSCRIPTION INITIATION;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN; CYCLIN E; GENE DOSAGE; GENOME, HUMAN; HEAD AND NECK NEOPLASMS; HUMANS; ONCOGENE PROTEINS; RECURRENCE; RNA, MESSENGER; SOXB1 TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS;

EID: 74949090477     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20714     Document Type: Article

References (37)

1. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. 2005. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65:7561-7567.
2. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499-507.
3. Biermann K, Heukamp LC, Steger K, Zhou H, Franke FE, Sonnack V, Brehm R, Berg J, Bastian PJ, Muller SC, Wang-Eckert L, Buettner R. 2007. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors. Cancer Genomics Proteomics 4:359-367.
4. Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I. 2000. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157:369-375.
5. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W, Sun L, Yang X, Wang Y, Zhang Y, Shang Y. 2008. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283:17969-17978.
6. Choi S, Myers JN. 2008. Molecular pathogenesis of oral squamous cell carcinoma: Implications for therapy. J Dent Res 87:14-32.
7. duManoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T. 1995. Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
8. Freier K, Bosch FX, Flechtenmacher C, Devens F, Benner A, Lichter P, Joos S, Hofele C. 2003a. Distinct site-specific oncoprotein overexpression in head and neck squamous cell carcinoma: A tissue microarray analysis. Anticancer Res 23:3971-3977.
9. Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C. 2003b. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63:1179-1182.
10. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Joos S. 2006. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45:118-125.
11. Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL. 2004. OCGR array: An oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40:511-519.
12. Groot PC, Bleeker MJ, Pronk JC, Arwert F, Mager WH, Planta RJ, Eriksson AW, Frants RR. 1989. The human a-amylase multigene family consists of haplotypes with variable numbers of genes. Genomics 5:29-42.
13. Groot PC, Mager WH, Frants RR. 1991. Interpretation of polymorphic DNA patterns in the human a-amylase multigene family. Genomics 10:779-785.
14. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, Magaud JP, Rimokh R. 1998. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-2954.
15. Hermsen MA, Joenje H, Arwert F, Braakhuis BJ, Baak JP, Westerveld A, Slater R. 1997. Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Oral Oncol 33:414-418.
16. Hever AM, Williamson KA, van Heyningen V. 2006. Developmental malformations of the eye: The role of PAX6, SOX2 and OTX2. Clin Genet 69:459-570.
17. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
18. Kallioniemi A. 2008. CGH microarrays and cancer. Curr Opin Biotechnol 19:36-40.
19. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E, Dohner H, Stilgenbauer S, Lichter P. 2002. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 99:4554-4561.
20. Liu CJ, Lin SC, Chen YJ, Chang KM, Chang KW. 2006. Arraycomparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 45:721-731.
21. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, Ko MS, Niwa H. 2007. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9:625-635.
22. Mendrzyk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Stange DE, Neben K, Fiegler H, Carter NP, Reifenberger G, Korshunov A, Lichter P. 2005. Genomic and protein expression profiling identi.es CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol 23:8853-8862.
23. Nakamura E, Kozaki K, Tsuda H, Suzuki E, Pimkhaokham A, Yamamoto G, Irie T, Tachikawa T, Amagasa T, Inazawa J, Imoto I. 2008. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamouscell carcinoma. Cancer Sci 99:1390-1400.
24. Razanajaona D, Joguet S, Ay AS, Treilleux I, Goddard-Leon S, Bartholin L, Rimokh R. 2007. Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth. Cancer Res 67:7223-7229.
25. Redon R, Hussenet T, Bour G, Caulee K, Jost B, Muller D, Abecassis J, du Manoir S. 2002. Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. Cancer Res 62:6211-6217.
26. Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K, Tsutani Y. 2006. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: Comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 32:164-170.
27. Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, Sauter G. 2003. Cyclin E overexpression and amplification in human tumours. J Pathol 200:375-382.
28. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Dohner H, Bentz M, Lichter P. 2004. Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101:1039-1044.
29. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P. 1997. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20:399-407.
30. Sticht C, Hofele C, Flechtenmacher C, Bosch FX, Freier K, Lichter P, Joos S. 2005. amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC). Br J Cancer 92:770-774.
31. Sticht C, Freier K, Knop.e K, Flechtenmacher C, Pungs S, Hofele C, Hahn M, Joos S, Lichter P. 2008. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia 10:462-470.
32. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki KI, Amagasa T, Inazawa J. 2007. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamouscell carcinomas by aberrant promoter hypermethylation. Oncogene 26:7921-7932.
33. Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M. 2005. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 46:649-658.
34. Weber RG, Scheer M, Born IA, Joos S, Cobbers JM, Hofele C, Reifenberger G, Zoller JE, Lichter P. 1998. Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization. Am J Pathol 153:295-303.
35. Wicha MS, Liu S, Dontu G. 2006. Cancer stem cells: An old idea-a paradigm shift. Cancer Res 66:1883-1890; discussion 1895-1896.
36. Yamada S, Sumrejkanchanakij P, Amagasa T, Ikeda MA. 2004. Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway. Int J Cancer 111:17-22.
37. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, Lohmann DR, Lichter P. 2005. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 43:294-301.